Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
GLP-1 Meal Plan Delivery $94.95 Protein-packed, portion-controlled meals that work with your medication not against it
Peer review Peer review information Nature Reviews Endocrinology thanks Geltrude Mingrone, Alex Miras, Pirjo Nuutila and Antonio Ettore Pontiroli for their contribution to the peer review of this work
Foundayo (Orforglipron) Approved in April 2026, Foundayo is the newest FDA-approved GLP-1 medication, available as a daily pill that offers flexibility with no dietary restrictions
Combination in patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment with Metformin alone, Sulfonylurea alone, Basal Insulin alone or Metformin in Combination with either Sulfonylurea or Basal Insulin In a 26-week, double-blind trial (Trial 5, NCT02827708), 324 adult patients with moderate renal impairment (eGFRCKD-EPI 30 to 59 mL/min/1.73 m2) were randomized to semaglutide tablets 14 mg orally once daily or placebo once daily
US$ 21.86
US$ 29.01
US$ 26.62
US$ 23.21
US$ 20.54
US$ 29.81
US$ 27.55
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)